US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist
  • 2.030
  • -6.540-76.31%
Close Nov 29 13:00 ET
  • 2.140
  • +0.110+5.42%
Post 16:07 ET
236.20MMarket Cap-1429P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Applied Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.350M--
--2024/Q4-- / 1.064M--
--2024/Q3122.000K / 0.000--
--2024/Q2144.000K / 2.500M--
--2024/Q1190.000K / 2.500M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.350M--
--2024/Q4-- / 1.064M--
--2024/Q3122.000K / 0.000--
--2024/Q2144.000K / 2.500M--
--2024/Q1190.000K / 2.500M--

Unlock Free Earnings Estimates

Applied Therapeutics Earnings Reports

  • Applied Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:33 ET

  • Applied Therapeutics | 8-K: Applied Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 7 07:23 ET

  • Applied Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 07:16 ET

  • Applied Therapeutics | 8-K: Applied Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 7 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 29, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data